“Just as the pharmaceutical industry realized, the devices industry can benefit
from cloud platforms that allow companies to manage more with less.”
~ Andrew Tummon
A multitenant cloud solution like Veeva CRM saves companies from having to purchase expensive hardware,
troubleshoot problems, or maintain the infrastructure. The
provider handles all system upgrades, which are transparent
and automatic to users who benefit from always working on
the latest application release.
Because the model is scalable, companies can quickly
make changes and deploy new features and functionality
in response to regulatory changes, market fluctuations, and
technology innovation. In a client/server environment, a
simple field change may require weeks to months of recon-figurations and data migrations. Changes in a multitenant
cloud system take just minutes.
“As new regulations force medical device companies to
conduct more clinical studies to remain in compliance, new
technology platforms will help them to work more efficiently,” Tummon concludes. “While medical devices remain a
high-growth area in terms of innovation, next-generation
technology is the key to working smarter, faster and maintaining the competitive edge.” •
SOURCES:
1. AT Kearney “Medical Devices: Equipped for the Fu-
ture?” https://www.atkearney.com/docu-
ments/10192/5227116/Medical+Devices+-
+Equipped+for+the+Future.pdf
2. Medtech Europe, “The European Medical Technology
Industry, in figures,” pg. 21. http://www.medtecheu-
rope.org/sites/default/files/resource_items/files/
MEDTECH_FactFigures_ONLINE3.pdf
3. Deloitte & Company, “2017 Global Life Sciences Outlook: Thriving in today’s uncertain market,” pg. 9. https://
www2.deloitte.com/content/dam/Deloitte/global/
Documents/Life-Sciences-Health-Care/gx-lshc-
2017-life-sciences-outlook.pdf COMMENT
Melonie Warfel
VP of Medical
Devices &
Diagnostics
Veeva Systems
Melonie has more
than 25 years of technology experience,
with expertise across multiple verticals—
including life sciences, healthcare,
manufacturing, and government. As vice
president of medical device & diagnostics
at Veeva Systems, she is responsible for
MD&D strategy, customer engagement,
business development, strategic alliances,
and market adoption. Before her role
in MD&D, Warfel was vice president
of Vault platform, where she was
responsible for new market development,
solution identification, customer
engagements, and go-to-market activities.
Prior to joining Veeva, Warfel spent
six years building and growing the life
sciences practice at l Pegasystems, and
19 years at Adobe Systems, where she
drove the development of the company’s
vertical business strategy.
melonie.warfel@veeva.com
Veeva Systems Inc. is a leader in
cloud-based software for the global
life sciences industry. Committed to
innovation, product excellence, and
customer success, Veeva has more
than 550 customers, ranging from
the world’s largest pharmaceutical
companies to emerging biotechs. Veeva
is headquartered in the San Francisco Bay
Area, with offices in Europe, Asia, and
Latin America. For more information, visit
veeva.com.
